Introduction
Despite considerable national, regional and global efforts targeted at the prevention of iron deficiency (ID), it remains among the most common nutritional problem in the world (WHO, 2001) . In developing countries, dietary inadequacy and infections such as malaria, hookworm and HIV are the principal causes of ID and its consequent anemia (Stoltzfus et al., 2005) . One factor impeding progress in reducing ID is the absence of international agreement on which indicators to use to assess iron status (WHO/CDC, 2005) . Infections can influence iron metabolism via the acute phase response (APR) a generalized reaction of the body to inflammation (Wieringa et al., 2002; Tomkins, 2003) . This in turn influences several indicators of iron status, most notably serum ferritin (SF), which can be raised many fold during the APR (Thurnham and Northrop-Clewes, 2004) . Therefore, accurate assessment of iron status in populations where there is a high prevalence of infection and inflammation is challenging.
Measurement of an acute phase protein (APP) in population surveys to aid in the interpretation of iron status indicators is becoming routine. For example, concurrent measurement of an APP with SF facilitates distinguishing whether a high SF is a consequence of iron metabolism or inflammation (Witte, 1991) . APPs frequently reported for this purpose include C-reactive protein (CRP), a-1-acid glycoprotein (AGP) and a-1-antichymotrypsin (ACT), with CRP the most frequently used APP in population surveys. There is no agreement on which APP is best, what cutoffs to use or how to use the APP to best interpret iron indicators. One method frequently employed is to exclude all individuals with APP concentrations above a certain threshold. However, in areas where infections are highly prevalent, this method will reduce the sample size substantially and not be adequately representative. A second less widely used method is to control for high SF concentrations using an APP, for example, using an APP as a covariate in a regression model. There is, however, no established method for doing this.
A recent WHO/CDC expert consultation on assessing iron status of populations called for exploratory analyses using data sets that include hemoglobin (Hb), SF and transferrin receptor (TfR), and at least one APP with CRP, ACT or AGP as the first choice (WHO/CDC, 2005) . The consultation further suggested that AGP may be a better indicator than CRP or ACT of the presence of chronic, sub-clinical infection because it most closely reflects changes in SF concentration during infection. To date, there have been no published studies examining the relationship between iron status indicators and AGP among HIV infected individuals.
The objectives of this study were to examine the relationships between AGP concentrations and concentrations of Hb, SF, TfR and the TfR-log 10 SF ratio in HIV-positive postpartum women, and to examine the expected relationships between commonly used iron status indicators among women with high and low AGP concentrations.
Subjects and methods
The study was conducted using archived plasma and serum samples and data collected as part of ZVITAMBO, a clinical trial testing the impact of postpartum maternal and neonatal vitamin A supplementation on several health outcomes, as described previously (Humphrey et al., 2006a, b) . Briefly, the ZVITAMBO trial recruited 14 110 mother-infant pairs within 96 h after delivery at maternity clinics and hospitals in Harare from November 1997 to January 2000. Mother-infant pairs were eligible if neither had an acutely life-threatening condition, the infant was a singleton with birth weight X1500 g and the mother planned to stay in Harare after delivery. Mothers were tested for HIV at baseline, as previously described (Humphrey et al., 2006b) . CD4 cells were enumerated within 48 h of phlebotomy (Facscount, Becton Dickinson International, Erembodegem, Belgium) for all HIV-positive women. Staging of HIV disease by WHO criteria at recruitment was not carried out. Hb was measured on the same day as blood collection among all women enrolled after 1 October 1999 (about 60% of the total) using the HemoCue Hemoglobinometer (HemoCue, Mission Viejo, CA, USA). Remaining plasma and serum were separated and archived at À70 1C.
For this analysis, we drew on archived plasma and serum samples of HIV-positive mothers for whom Hb had been measured at baseline. To ensure that we could investigate the relationships between iron status indicators across the spectrum of severity of HIV infection, we selected all mothers with CD4 counts o200 cells Â 10 6 /l, and a 20% random sub-sample of those with CD4 counts 200-400 and 4400 cells Â 10 6 /l. Because there were fewer women with CD4 counts o200 cells/ml in the larger ZVITAMBO cohort, we over sampled these women. 
Statistical analysis
Plasma SF and TfR concentrations were normalized by log 10 transformation; geometric means (95% CI) are reported. An AGP cutoff 41 g/l was used to define a positive APR (Filteau et al., 1993) ; an Hb cutoff o110 g/l was used to define anemia (WHO, 2001 between the APR and these indicators. Main effects were considered significant at an a ¼ 0.05, and interactions at an a ¼ 0.10. We additionally controlled for maternal age and the time elapsed between delivery and sample blood draw (measured to within 1 h) to account for any hematological changes that occur in the immediate postpartum period, particularly decreasing Hb concentrations, but these adjustments only marginally influenced independent coefficients, and did not alter interpretation of regression models.
To assess the magnitude of the difference between APRpositive and APR-negative women, we calculated adjusted least-squares means estimates from our regression models for each level of the independent variable of interest. All statistical analyses were carried out using STATA 8 software.
Results
Detailed information on health status and symptoms were not available on these women. Of the 643 HIV-positive women, 238 (37%) were APR-positive, 302 (47%) anemic and about one-third iron deficient using either SF or TfR (Table 1) . CD4 counts were obtained at baseline, and 13% had CD4 counts o100 cells/ml (54% of whom were APR-positive), 31% had CD4 counts between 100-200 cells/ml (38% APRpositive), 26% had CD4 counts between 200-400 cells/ml (30% APR-positive) and 30% had CD4 counts 4400 cells/ml (34% APR-positive). Compared to APR-negative women, APR-positive women had significantly lower Hb concentrations and TfR-log 10 SF ratios and higher SF and EPO concentrations; TfR concentrations were not different between the groups. Similarly, concentrations of Hb, SF and TfR-log 10 SF ratio differed significantly across quartiles of AGP, but TfR concentrations did not (Table 2 ). There was a gradual increase in SF with each sequential AGP quartile. Mean Hb and EPO concentrations did not differ across the first three AGP quartiles, but Hb was significantly lower and EPO significantly higher among women in the highest AGP quartile compared to the first three.
The APR significantly modified the relationship between SF and Hb ( Figure 1 ). After controlling for maternal age and the time elapsed between delivery and the sample blood draw this interaction remained significant (interaction P ¼ 0.095). Therefore, the relationship between Hb and SF was investigated across increasing Hb categories from o90 to 4120 g/l, separately for APR-positive and APR-negative women (Table 3 ). We present the results from regression models within each Hb category that control for maternal age and the time elapsed between delivery and sample blood draw. These values may be interpreted as the adjusted geometric mean (95% CI) concentration of either SF (Table 3) or TfR (Table 4) , adjusted for the mean value for maternal age and time elapsed between delivery and sample blood draw within each Hb category.
For every Hb category, mean SF was higher for APRpositive compared to APR-negative women (Table 3) . SF increased with increasing Hb (linear trend test, Po0.001) among APR-negative women, but not among APR-positive women (linear trend test, P ¼ 0.141). Similarly, the relationship between Hb and TfR was investigated across the increasing Hb categories for APR-positive and APR-negative women (data not shown), though the APR did not modify the relationship between TfR and Hb (interaction P ¼ 0.337; Figure 2 ). Mean TfR did not differ significantly between APR-positive and APR-negative women in any Hb category, though the point estimate was slightly lower among APRpositive compared to APR-negative women in all but one Hb category, and there appeared to be a greater difference in TfR concentrations in anemic women. When adjusting for Hb categories (either as a continuous or as dummy variables), maternal age and the time elapsed between delivery and sample blood draw, the main effect of the APR was not significant (P ¼ 0.110).
When the relationship between TfR and Hb was examined among anemic (Hb o110 g/l) and non-anemic women separately, there was a marginally statistically significant decrease in TfR concentration among anemic APR-positive women (P ¼ 0.053), but not among non-anemic women (P ¼ 0.866) ( Table 4 ). The magnitude of this decrease in TfR concentrations was 0.9 mg/ml.
Although mean EPO concentration was significantly higher among APR-positive women (Table 1) , the APR did not modify the relationship between Hb and EPO (P ¼ 0.891), indicating that the response of EPO to decreasing Hb concentrations was not different among APR-positive and APR-negative women (Figure 3) . Additionally, after controlling for Hb, maternal age Acute phase response and iron status in HIV-infected Zimbabwean women R Rawat et al and the time elapsed between delivery and sample blood draw, the main effect of the APR on EPO concentrations was not significant (P ¼ 0.974).
Discussion
Our results suggest that when measuring iron status in individuals living in HIV endemic areas, AGP can be employed as a screening test to identify individuals for whom SF will accurately reflect ID. Among individuals with AGP concentrations o1 g/l, SF appears to be informative of iron stores. Among those with AGP41 g/l, SF should not be measured as it no longer reflects iron stores but instead reflects its behavior as an APP. In these individuals, no assessment of iron stores can be made outside of staining bone marrow aspirates that are not practical for population assessment. At AGP concentrations above and below 1 g/l, TfR is inversely associated with Hb, and can be used as a marker of iron status when AGP is elevated. However, it appears incorrect to assume that TfR is uninfluenced by inflammation in the context of HIV infection. We see a slight decrease in TfR with inflammation, but this decrease appears to occur only among anemic individuals. If a standard cutoff to define ID using TfR were established, it might be useful to lower this cutoff among anemic individuals with elevated AGP concentrations. We propose that AGP be measured in surveys to assess iron status and determinations of whether to further measure SF or TfR be based on this AGP measurement. Measurement of AGP using the radial immunodiffusion kit that we used is relatively cheap (BUS$ 2/ sample) and requires little technical laboratory experience, whereas measurement of SF and TfR by ELISA is more expensive (US$ 5-10 and US$ 10-15, respectively) and technically intensive. In this population, AGP captured the influence of the APR on Hb and SF concentrations. At an AGP41 g/l to define the presence of an APR, mean Hb concentrations was significantly lower, and the prevalence of anemia significantly higher, among APR-positive compared to APR-negative women. We posit that the anemia in this group reflects, in part, the anemia of chronic disease (ACD), a type of anemia that is mediated by pro-inflammatory cytokines that induce changes in iron homeostasis, the proliferation of erythroid progenitor cells, the production of EPO and the life span of RBCs, all of which contribute to the pathogenesis of anemia (Weiss and Goodnough, 2005) . This is supported by increased SF concentrations, alongside low Hb concentrations and mildly lower TfR concentrations. If the anemia were predominantly ID anemia, we would expect to see lower SF and higher TfR concentrations as a result of increased expression of transferrin receptors on developing erythroblasts, reflecting compromised iron availability.
Although SF was positively correlated with AGP across its entire distribution, this relationship was strongest at AGP41 g/l. The relationship between Hb and SF also differed by APR status. Among APR-negative women, there was a strong positive linear relationship between Hb and SF, which was absent among APR-positive women. Thus, AGP41 g/l appeared to distinguish women in whom SF primarily reflected the APR from those in whom SF primarily reflected iron stores.
The main advantage of TfR over SF to define ID is that TfR is not an APP, and therefore is purported to be uninfluenced by a range of infections and inflammatory conditions (Ferguson et al., 1992; Beguin, 2003) . In our study mean TfR concentrations did not differ between APR-positive and APR-negative women, initially consistent with the idea that TfR is independent of inflammation (Ferguson et al., 1992; Beguin, 2003) . However, among anemic women, TfR concentrations were significantly lower among APRpositive compared to APR-negative women. This may reflect suppression of erythropoeisis caused by pro-inflammatory cytokines such as IL-1, IL-6 and TNF-a, which result in increased AGP concentration (Gabay and Kushner, 1999; Fournier et al., 2000) and are also known to be associated with HIV-infection (Semba and Gray, 2001 ). These proinflammatory cytokines can interact with the hematopoietic system at several levels, resulting in impaired erythropoeisis. This can happen via three proposed mechanisms (Spivak, 2000; Stenvinkel, 2003; Weiss and Goodnough, 2005) : (i) cytokines have been shown to inhibit EPO production (Jelkmann, 1998) , suggesting that during inflammation the EPO response of the kidney to decreasing Hb concentrations is blunted, (ii) cytokines are thought to impair responsiveness of erythroid progenitor cells in the bone marrow to EPO stimulation, and have been shown to interfere with their proliferation (Jelkmann, 1998; Spivak, 2000; Weiss and Goodnough, 2005) and (iii) increased erythrophagocytosis has been associated with inflammation and is thought to lead to decreased erythrocyte life span (Weiss and Goodnough, 2005) . These mechanisms likely play a role in impaired erythroid response to decreasing Hb levels, which we observe in the form of decreased TfR concentrations. The absence of a similar observation among non-anemic women is likely because the physiologic feedback system involving EPO production and the subsequent bone marrow response for production of RBCs to correct for the degree of anemia does not play a role when anemia is absent. This feedback system kicks in primarily to correct anemia.
Several studies have shown TfR to be influenced by infection and inflammation, but none among HIV-infected individuals. Higher TfR concentrations among people infected with malaria (Mockenhaupt et al., 1999; Stoltzfus et al., 2000; Menendez et al., 2001; Verhoef et al., 2001) have led investigators to suggest that the high TfR reflects increased erythropoeisis resulting from malaria induced hemolysis. Others, however, have reported lower TfR concentrations during malaria suggestive of blunted erythropoeisis (Williams et al., 1999; Beesley et al., 2000) .
Because TfR is both a function of ID and erythropoeisis (Kohgo et al., 1987; Kling et al., 1998; Beguin, 2003) , we investigated the role of EPO production to further elucidate the potential mechanism for decreased TfR concentrations among APR-positive anemic women. Erythropoeisis is closely regulated by EPO, and EPO production is inversely related to tissue oxygenation and Hb levels (Spivak, 2000; Weiss and Goodnough, 2005) . We observe mean EPO concentrations significantly greater among APR-positive women, initially suggesting greater EPO production in these women. However, rather than only comparing the absolute EPO concentration by the APR, it is more appropriate to compare EPO responses to decreasing Hb concentrations. In our regression models comparing the relationship of plasma EPO to Hb concentrations separately for APR-negative and APR-positive women, there was no difference in the EPO-Hb slope, suggesting that the plasma EPO response to correct for the degree of anemia is not influenced by the APR. This observation is consistent with the observation that the EPO response per degree of anemia was similar among rats with acute inflammation compared to control animals (Leng and Folb, 1996) . We, therefore, believe that impaired bone marrow response to EPO stimulation, rather than EPO production, is the likely cause of the observed decrease in TfR concentration among APR-positive women. Possible mechanisms include circulating pro-inflammatory cytokines directly impairing bone marrow response to EPO stimulation and impaired proliferation of erythroid progenitor cells (Spivak, 2000; Weiss and Goodnough, 2005) , or from direct HIV infection of hematopoietic stem cells, progenitor cells and/or bone marrow stromal cells (Semba and Gray, 2001) .
It is important to understand that our characterization the APR should be interpreted with caution. We used a single APP, AGP, to characterize the APR. Therefore, our determination of APR-positive women is only reflected by women having AGP concentrations 41 g/l. As clinical sings of disease may have been present, there may be individuals who were misclassified using AGP, and that the use of a different APP or multiple APPs may have indicated the inflammation was more pronounced. There is no standardized method to capture the APR in population settings.
Understanding the time course of changes in concentrations of the most commonly used indicators of inflammation in nutritional surveys, helps to understand this problem of potential misclassification. There are three APPs that have most commonly been used to measure sub clinical inflammation in nutrition studies: ACT, CRP and AGP (Thurnham et al., 2003 (Thurnham et al., , 2005 . ACT is thought to be a good general marker of both acute and chronic infection. It rises rapidly following the initiation of the inflammatory response, and remains elevated for some time after clinical symptoms disappear. Plasma CRP increases rapidly within 5 h of infection, reaches a maximal concentration between 24 and 48 h and thereafter falls rapidly with disappearance of symptoms. Plasma AGP concentration is slower to rise and it is unusual to detect an elevation before 48 h. It reaches its maximal concentrations between 3-5 days following infection, but it is uncertain how long it will remain elevated following different infections (Thurnham et al., 2005) .
Although CRP has traditionally been used in nutritional surveys, its rapid rise and fall in concentration is one reason why it is being discouraged as a marker of inflammation when used to control for the increase in SF concentration that accompanies the APR. A better alternative to CRP is thought to be AGP, which remains elevated for a longer duration of time. One time course study that followed changes in concentration of multiple APPs and iron status measurements, found that SF concentrations rose steadily reaching a peak, like CRP, at day 2, but like AGP, remained elevated for several subsequent days (Feelders et al., 1998) . It is because of this extended period of elevation in SF and AGP that AGP is thought to better reflect the changes in SF that accompany the APR.
We conclude that AGP does reveal the influence of the APR on indicators of iron status, thereby confirming the WHO/ CDC recommendation for the use of this marker of inflammation when assessing the iron status of a population. To fully capture the influence of the APR on iron status indicators, it may be more appropriate to measure multiple APPs that capture both the initial and longer term changes in concentration of iron indicators that occur with the onset of inflammation (Feelders et al., 1998; Thurnham et al., 2005) . Additional studies that compare multiple markers of inflammation and their association with and influence on iron status indicators, are needed. Furthermore, we need time-course studies that closely follow changes in markers of inflammation and iron status indicators with different stimuli.
